Home / Collaborative Scientific Publications on VEGF-A
Berrahmoune H, Lamont J, Fitzgerald P, Visvikis-Siest S. Inter-individual variation of inflammatory markers of cardiovascular risks and diseases. Clin Chem Lab Med. 2005; 43(7): 671-84.
Berrahmoune H, Lamont JV, Herbeth B, FitzGerald PS, Visvikis-Siest S. Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular
Berrahmoune H, Herbeth B, Lamont JV, Masson C, Fitzgerald PS, Visvikis-Siest S. Heritability for plasma VEGF concentration in the Stanislas family study. Ann Hum Genet. 2007 Jan; 71(Pt 1):54-63.endothelial growth factor: Results from the STANISLAS cohort. Clin Chem. 2006 Mar; 52(3): 504-10.
Debette S*, Visvikis-Siest S*, Chen MH, Ndiaye NC, Song C, DeStefano AL, Safa R, Azimi-Nezhad M, Sawyer D, Marteau JB, Xanthakis V, Siest G, Sullivan L, Pfister M, Smith H, Choi SH, Lamont J, Lind L, Yang Q, Fitzgerald P, Ingelsson E, Vasan RS**, Seshadri S**. Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels. Circ Res. 2011 Aug 19; 109(5): 554-63. * co-first authors. ** co-last authors
Azimi-Nezhad M*, Stathopoulou MG*, Bonnefond A, Rancier M, Saleh A, Lamont J, Fitzgerald P, Visvikis-Siest S. Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population. 2013 Feb; 61(2): 602-7. *co-first authors
Stathopoulou MG*, Bonnefond A*, Ndiaye NC*, Azimi-Nezhad M, El Shamieh S, Saleh A, Rancier M, Siest G, Lamont J, Fitzgerald P, Visvikis-Siest S. A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C. J Lipid Res. 2013 Feb; 54(2): 535-41. *co-first authors
Saleh A*, Stathopoulou Mg*, Dade S, Ndiaye Nc, Azimi-Nezhad M, Murray H, Masson C, Lamont J, Fitzgerald P, Visvikis-Siest S. Angiogenesis related genes NOS3, CD14, MMP3 and IL4R are associated to VEGF gene expression and circulating levels in physiological conditions. BMC Medical Genetics. 2015 Oct 5;16: 904, 0234-6*. co-first authors. Facteur d’Impact: 2.08 * co-first authors
Choi SH*, Ruggiero D*, Sorice R*, Song C, Nutile T, Vernon Smith A, Pina Concas M, Traglia M, Barbieri C, Ndiaye NC, Stathopoulou MG, Lagou V, Battista Maestrale G, Sala C, E Debette SA, Kovacs P, Lind L, Lamont J, Fitzgerald P, Tönjes A, Guðnason V, Ingelsson E, Toniolo D, Pirastu M, Bellenguez C, Vasan RS, Leutenegger AL, Destefano AL, Visvikis-Siest S, Seshadri S**, Ciullo M**. Six novel loci associated with circulating VEGF levels identified by a meta-analysis of genome-wide association studies. PLoS Genet. 2016 Feb 24;12(2):e1005874. * co-first authors. ** co-last authors.
Zaaber I*, Rancier M*, Stathopoulou M, Saleh A, Marmouch H, Masson C, Murray H, Kurth MJ, Lamont J, Fitzgerald P, Mahjoub S, Said K, Bel Hadj Jrad Tensaout B, Mestiri S, Visvikis-Siest S. Plasma Vegf- Related Polymorphisms Are Implied In Autoimmune Thyroid Diseases. Autoimmunity. 2016 juin; 49(4) 229-35.* co-first Authors.
Rancier M*, Zaaber I*, Stathopoulou MG, Saleh A, Marmouch H, Masson C, Murray H, Kurth MJ, Lamont J, Fitzgerald P, Mahjoub S, Said K, Bel Hadj Jrad Tensaout B, Mestiri S, Visvikis-Siest S. New biomarkers in thyroiditis: VEGF 145, VEGF 189 and VEGF 165 (a and b) mRNAs. 2016; Aug 5:1-7. 2016 Sep;49(6):366-372 *co-first authors.
Stathopoulou Mg, Xie T, Ruggiero D, Chatelin J, Rancier M, Weryha G, Kurth Mj, Aldasoro Arguinano Aa, Gorenjak V, Petrelis Am, Dagher G, Dedoussis G, Deloukas P, Lamont J, Marc J, Simmaco M, Schaik Rhnv, Innocenti F, Merlin Jl, Schneider J, Alizadeh Bz, Ciullo M, Seshadri S, Visvikis-Siest S; VEGF Consortium. A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF Consortium. Clin Chem Lab Med. 2018 Mar 28;56(4):83-86. doi: 10.1515/cclm-2017-0838. Impact factor : 2.27
Azimi-Nezhad M, Mirhafez Sr, Stathopoulou Mg, Murray H, Ndiaye Nc, Bahrami A, Varasteh A, Avan A, Bonnefond A, Rancier M, Mehrad-Majd H, Herbeth B, Lamont J, Fitzgerald P, Ferns Ga, Visvikis-Siest S, Ghayour-Mobarhan M. The Relationship Between Vascular Endothelial Growth Factor Cis- and Trans-Acting Genetic Variants and Metabolic Syndrome. Am J Med Sci. 2018 Jun;355(6):559-565.
Gorenjak V, Vance DR, Stathopoulou MG, Dade S, Murray H, Masson C, Lamont J, Fitzgerald P, Visvikis-Siest S: Peripheral Blood Mononuclear Cells Extracts VEGF Protein Levels and VEGF MRNA: Associations with inflammation molecules in a healthy population. Plos One. 2019. 14(8): E0220902. Doi: 1371/Journal.Pone.0220902. Published Online 2019 Aug 16.
Gorenjak V, Vance D.R, Dade S, Stathopoulou MG, Doherty L, Xie T, Murray H, Masson C, Lamont J, Fitzgerald P, Visvikis-Siest S: Epigenome-Wide Association Study in healthy individuals identifies significant associations with DNA methylation and PBMCS extracts VEGF-A concentration Clinical Epigenetics. 2020, 12(1):79. Doi:1186/S13148-020-00874-W
Gorenjak V, Petrelis Am, Stathopoulou MG, Toupance S, Kumar S, Labat C, Masson C, Murray H, Lamont J, Fitzgerald P, Benetos A, Visvikis-Siest S, TELARTA Consortium. A genetic determinant of VEGF-A levels is associated with telomere attrition: Aging-us 2021 Oct18;13 doi: 10.18632/aging.203636
Kafyra M, Kalafati IP, Gavra I, Siest S, Dedoussis GV. Associations of VEGF-A-Related Variants with Adolescent Cardiometabolic and Dietary Parameters. Nutrients, 2023, DOI: 10.3390/NU15081884
